On January 26, 2026, ASP Isotopes Inc. entered into an agreement to purchase 4,356,918 shares of Opeongo's Series Seed-1 Preferred Stock at $2.2952 per share for a total investment of approximately $10 million, enhancing its position in the biotechnology sector.